#missioncancer
#horizoneu

PRIME-ROSE - Partners

PRIME-ROSE brings together 24 partners, including nine beneficiaries and fifteen associated partners, from altogether 18 European countries. Professor Kjetil Taskén, Head of Institute for Cancer Research at Oslo University Hospital in Norway is the coordinator of PRIME-ROSE. Prof Hans Gelderblom, Leiden University Medical Center, is co-coordinator.

Page Content

MAP

PRIME-ROSE Partner Sites

Beneficiaries

Oslo University Hospital (OUS)

Oslo,
Norway

Project coordinator (WP7), work package leader control cohorts (WP2) and expansion cohorts (WP3). Will in addition contribute to WP 1 (data aggregation), WP 5 (implementaion), WP6 (social innovation) and WP8 (dissemination)

Learn more >

Leiden University Medical Center (LUMC)

Leiden,
Netherlands

Work package leader data aggregation (WP1) and early access & drup repurposing (WP4). Will in addition co-coordinate the project (WP7) and contribute to WP3 (expansion cohorts and WP6 (social innovation).

Learn more >

Swedish Institute for Health Economics (IHE)

Stockholm,
Sweden

Work package leader implementation in everyday practice (WP5).

Learn more >

Stockholm School of Economics Institute for Research (SIR)

Stockholm,
Sweden

Work package leader social innovation (WP6).

Learn more >

Helsinki University Hospital (HUS)

Helsinki,
Finland

Work package leader dissemination (WP8). Will in addition contribute to WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Capital Region of Denmark

Copenhagen,
Denmark

Participation in WP1 (data aggregation), WP3 (expansion cohorts), WP6 (social innovation).

Learn more >

Centre Leon Berard

Lyon,
France

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)

Porto,
Portugal

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Region Uppsala

Uppsala,
Sweden

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Associated Partners

Karolinska Institutet

Stockholm,
Sweden

Participation in WP1 (data aggregation) and WP3 (expansion cohorts).

Learn more >

Region Skåne

Skåne,
Sweden

Participation in WP1 (data aggregation) and WP3 (expansion cohorts).

Learn more >

Heidelberg University Hospital

Heidelberg,
Germany

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Maria Sklodowska-Curie Institute of Oncology

Warsaw,
Poland

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

University Hospital of Split (KBC Split)

Split,
Croatia

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Tartu University Hospital (TUH)

Tartu,
Estonia

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

National Institute of Oncology (NIO)

Budapest,
Hungary

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Vall D’Hebron Institute of Oncology (VHIO)

Barcelona,
Spain

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Center for Personalized Cancer Treatment hosted by Radboud University Medical Center

Nijmegen,
Netherlands

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

National Cancer Institute (NVI)

Vilnius,
Lithuania

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Cancer Research UK (CRUK)

London,
United Kingdom

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

University of Manchester

Manchester,
United Kingdom

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Trinity College Dublin

Dublin,
Ireland

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Masaryk Memorial Cancer Institute (MMCI)

Brno,
Czech Republic

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >

Center for Innovation in Medicine (InoMed)

Bucharest,
Romania

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Learn more >